Ergo Science Corp
OTC:ERGN
Relative Value
There is not enough data to reliably calculate the relative value of ERGN.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
ERGN Competitors Multiples
Ergo Science Corp Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
Ergo Science Corp
OTC:ERGN
|
55.2B USD | 2 160.3 | -12 841.6 | -10 816.3 | -10 391 | ||
CA |
A
|
Advance Lithium Corp
XTSX:AALI
|
576.3B CAD | 0 | -159 712.1 | -888 213 | -888 213 | |
US |
G
|
Gould Investors LP
OTC:GDVTZ
|
301B USD | 0 | 0 | 0 | 0 | |
US |
C
|
Carson Energy Development Corp
OTC:CDVM
|
270.6B USD | 263 524.8 | -70 424.1 | -77 926.9 | -77 525.1 | |
NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
80.5B Zac | 0 | 0 | 0 | 0 | |
US |
Liberty Bancshares Inc
OTC:LBSI
|
55.5B USD | 0 | 0 | 0 | 0 | ||
US |
H
|
HK Graphene Technology Corp
OTC:HKGT
|
53.9B USD | 0 | -33 104.9 | -34 818.3 | -34 818.3 | |
ID |
Amman Mineral Internasional Tbk PT
IDX:AMMN
|
620.3T IDR | 13.8 | 35.8 | 25.6 | 25.6 | ||
US |
M
|
Myson Group Inc
OTC:MYSN
|
38.4B USD | 0 | 0 | 0 | 0 | |
US |
N
|
Nuoncology Labs Inc
OTC:NLAB
|
29.3B USD | 0 | -1 004 063.9 | -1 004 063.9 | -1 004 063.9 | |
US |
Coupang Inc
F:788
|
26.2B EUR | 1.2 | 20.8 | 31.9 | 50.4 |